This is Evira
A medical-technology company with roots in science and technology — founded at Karolinska Institutet and KTH Royal Institute of Technology. We believe every person living with obesity has the right to effective, evidence-based care.
Our journey
- 2018
First clinical study results. Pilot at Martina Children's Hospital. CE-marked Class I.
- 2019
Winner of Swedbank Rivstart and SEIF Award.
- 2020
Feasibility study published in BMC Pediatrics. Platform validated at three sites.
- 2022
One-year study published in International Journal of Obesity. Expansion across Sweden.
- 2023
Won procurement from NHS England. Entered the UK market.
- 2025
Three-year follow-up published — no weight regain. RCT for GLP-1 in adolescents initiated at five Swedish university clinics.
- 2026
7,000+ paediatric patients, 3,000+ adult users.
Evira is in use here
Evira is deployed in NHS specialist services, community paediatric teams and private providers across the UK — and at clinics across Sweden and several other countries.
The UK sites are CEW clinics (Complications from Excess Weight) — NHS specialist clinics for children and young people living with obesity and its related conditions. Read more at NHS England.
Ashford and St Peters
London Rd, Stanwell, Ashford TW15 3AA
Directions →Birmingham Women's and Children's Hospital
St. Chads Tunnel, Birmingham B4 6NH
Directions →University Hospitals Bristol and Weston
Upper Maudlin St, Bristol BS2 8HW
Directions →Frimley Health
Portsmouth Rd, Camberley GU16 7UJ
Directions →Cambridge University Hospitals
Hills Rd, Cambridge CB2 0QQ
Directions →East Suffolk and North Essex
Turner Rd, Colchester CO4 5JL
Directions →Dartford
Darenth Wood Rd, Dartford DA2 8DA
Directions →University Hospitals of Leicester
Infirmary Square, Leicester LE1 5WW
Directions →
Get in touch
Clinician, commissioner, researcher or provider — we'd love to talk.